Search for: "Johnson v. Eli Lilly and Company et al"
Results 1 - 12
of 12
Sorted by Relevance
|
Sort by Date
24 May 2012, 12:02 pm
Eli Lilly & Co. and Jirak et al. v. [read post]
24 May 2012, 1:02 pm
Eli Lilly & Co. and Jirak et al. v. [read post]
15 Jan 2008, 3:06 am
Match.Com, LP et al filed 01/30/07 1:07-cv-00591 Guan Gao Company, Ltd. et al v. [read post]
31 Jan 2007, 9:51 am
Eli Lilly and Company - employment issues, more coming Marietta Squibb v. [read post]
31 May 2019, 9:47 am
Long post, lots of stuff to cover in this opinion.MillerCoors, LLC v. [read post]
27 Oct 2011, 4:24 am
Eli Lilly paid $1.4 billion for Zyprexa marketing. [read post]
29 Dec 2010, 12:54 pm
Eli Lilly & Co., 620 F.3d 121 (2d Cir. 2010). [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human… [read post]
2 Aug 2014, 6:05 am
Johnson, 70 Ill. [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007:… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
17 Mar 2020, 1:32 pm
One lot of Glucagon Emergency Kits have been recalled by Eli Lilly and Company due to a potentially dangerous loss of potency. [read post]
